Search

Your search keyword '"Iskar, Murat"' showing total 168 results

Search Constraints

Start Over You searched for: Author "Iskar, Murat" Remove constraint Author: "Iskar, Murat"
168 results on '"Iskar, Murat"'

Search Results

2. Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastoma

4. Proteogenomics refines the molecular classification of chronic lymphocytic leukemia

6. Integrative multi-omics identifies regulatory and exhausted T cell types and novel immunotherapy targets in CLL lymph nodes

7. Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines

9. Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations

13. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

14. The landscape of viral associations in human cancers

15. Combined burden and functional impact tests for cancer driver discovery using DriverPower

16. Integrative pathway enrichment analysis of multivariate omics data

17. Pathway and network analysis of more than 2500 whole cancer genomes

18. Divergent mutational processes distinguish hypoxic and normoxic tumours

19. Genomic footprints of activated telomere maintenance mechanisms in cancer

21. Luminal signalling links cell communication to tissue architecture during organogenesis

22. A synergistic interaction between HDAC‐ and PARP inhibitors in childhood tumors with chromothripsis

23. Proteogenomics refines the molecular classification of chronic lymphocytic leukemia

24. Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity

25. A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsis

26. Pan-cancer analysis of whole genomes

27. The landscape of viral associations in human cancers

28. Proteogenomic Subtyping of Chronic Lymphocytic Leukemia Identifies a Novel Poor Outcome Subgroup with a Distinct Drug Response Profile

31. IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression

33. Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations

34. Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration

36. Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks

37. DECIPHER pooled shRNA library screen identifies PP2A and FGFR signaling as potential therapeutic targets for diffuse intrinsic pontine gliomas

39. CD8+ T-cells of CLL-bearing mice acquire a transcriptional program of T-cell activation and exhaustion.

41. Rapid proteotyping reveals cancer biology and drug response determinants in the NCI-60 cells

43. Tumor-derived exosomes modulate PD-L1 expression in monocytes

47. The endosomal transcriptional regulator RNF11 integrates degradation and transport of EGFR

Catalog

Books, media, physical & digital resources